Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion

C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础

基本信息

  • 批准号:
    10512236
  • 负责人:
  • 金额:
    $ 62.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-15 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Nucleotide repeat elements, including microsatellites or short tandem repeats, are common in eukaryotic genomes. Expansions of short nucleotide repeats have been linked to over 50 different types of genetic disorders, primarily neurological and neuromuscular disorders. Our understanding of how these repeat elements in the human genome cause diseases is still in its infancy. A hexanucleotide repeat expansion in a noncoding region of the C9orf72 gene has been linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is characterized by loss of motor neurons, and the C9orf72 hexanucleotide repeat expansion represents the most common genetic cause of both familial and sporadic ALS. FTD is characterized by degeneration of the frontal and temporal lobes of the brain and is the second-most common type of dementia in people older than 65; the C9orf72 hexanucleotide repeat expansion is also the most common genetic cause of FTD. This repeat expansion is also found to contribute to Alzheimer’s disease and Huntington’s disease. To help relieve the public health burden associated with these diseases, it is important to understand the mechanisms underlying their pathogenesis. Multiple hypotheses exist to explain the pathogenic mechanisms underlying C9orf72-linked ALS/FTD. The goal of the proposed project is to elucidate novel mechanisms through which the C9orf72 hexanucleotide repeat expansion leads to molecular defects and neuronal toxicity, focusing on gain-of-function mechanisms. The specific aims are to identify previously unknown pathogenic cascades initiated by the C9orf72 hexanucleotide repeat expansion. These novel pathogenic cascades include, but are not limited to, RNA toxicity and non-canonical translation products resulting from the C9orf72 hexanucleotide repeat expansion. We propose a series of fundamental studies that combine biochemical, molecular, and genetic approaches to shed light on the novel pathways leading to ALS/FTD pathogenesis and to identify potential intervention strategies. Successful completion of the project is expected to provide insights into fundamental mechanisms of neurodegeneration in ALS/FTD that may ultimately lead to novel approaches for treating ALS/FTD and other relevant neurodegenerative diseases.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiou Wang其他文献

Jiou Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiou Wang', 18)}}的其他基金

Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础
  • 批准号:
    10659232
  • 财政年份:
    2022
  • 资助金额:
    $ 62.76万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10530653
  • 财政年份:
    2019
  • 资助金额:
    $ 62.76万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10401555
  • 财政年份:
    2019
  • 资助金额:
    $ 62.76万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10318610
  • 财政年份:
    2019
  • 资助金额:
    $ 62.76万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10400837
  • 财政年份:
    2015
  • 资助金额:
    $ 62.76万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10606605
  • 财政年份:
    2015
  • 资助金额:
    $ 62.76万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10133157
  • 财政年份:
    2015
  • 资助金额:
    $ 62.76万
  • 项目类别:
Investigating disease Mechanisms in C9orf72-linked ALS/FTD
研究 C9orf72 相关 ALS/FTD 的疾病机制
  • 批准号:
    9066822
  • 财政年份:
    2015
  • 资助金额:
    $ 62.76万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    9904831
  • 财政年份:
    2015
  • 资助金额:
    $ 62.76万
  • 项目类别:
Neurodegeneration and Proteotoxicity Dissected in C. elegans and Mammals
线虫和哺乳动物的神经变性和蛋白质毒性剖析
  • 批准号:
    9281039
  • 财政年份:
    2011
  • 资助金额:
    $ 62.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了